A transparent, rules-based read on the fundamentals — each pillar scored 0–100 from the metrics on this page. A starting point for research, not investment advice.
Trailing fundamentals and forward valuation at a glance.
Latest headlines mentioning West Pharmaceutical Services, Inc..
West Appoints Michel Lagarde to be President and Chief Executive Officer
West Pharmaceutical Names Michel Lagarde CEO
NTRA & Diakonos Partner to Use Signatera in Refractory Melanoma Trial
PacBio Expands HiFi Sequencing Reach With New SPRQ-Nx Technology
Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?
HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y
Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating
Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
www.westpharma.comData via Polygon & Yahoo Finance. For research and educational purposes only — not investment advice. As of 6/2/2026, 2:22:39 AM.